Although the prognostic role and clinical application of CTLA-4 in tumors are still controversial, increased CTLA-4 expression on T cells contributes to poor prognosis in various cancers including DLBCL [41, 42]. The gene discussed is CTLA4; the disease is diffuse large B-cell lymphoma.